Inventor

OWENS ANDREW PATE

GB33 patents

⚠️ This page may combine multiple inventors who share the name “OWENS ANDREW PATE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OWENS ANDREW PATE

MERCK SHARP & DOHME

Imidazo-pyridine derivatives as ligands for GABA receptors

Cyclohexyl sulphones as gamma-secretase inhibitors

Tricyclic pyridone analogues as GABA-A receptor ligands

Gamma-secretase inhibitors

Triazolo-pyridazine derivatives as ligands for GABA receptors

Benzodiazepine derivatives as inhibitors of gamma secretase

Benzodiazepine derivatives as APP modulators

Ethane-1-2-diamine derivatives and tachykinin antagonists

Morpholine derivatives and their use as therapeutic agents

Tetrahydropyridine derivatives as dopamine receptor subtype ligands

Morpholine derivatives and their use as therapeutic agents

N-(2-benzyloxy-1-phenethyl)-N-(2&#39;-methoxyethyl)amino-methane compounds are useful as tachykinin antagonists

Inhibitors of Akt activity

Sulphones which modulate the action of gamma secretase

Sulphones for inhibition of gamma secretase

Cyclohexyl sulphones as gamma-secretase inhibitors

Cyclic sulfonamides for inhibition of gamma-secretase

Sulphones which modulate the action of gamma-secretase

USHER III INITIATIVE INC

Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome

Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome

Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome

Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome

Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome

Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome

Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome

USHER III INITIATIVE

Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome

Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome

VIALARD JORGE EDUARDO

Quinolinone derivatives as PARP and TANK inhibitors

Quinolinone derivatives as PARP and tank inhibitors

ALLEN DANIEL REES

Triazine derivatives as kinase inhibitors

Quinoline derivatives as kinase inhibitors

MERCK & CO INC

Inhibitors of Akt activity

BUERLI ROLAND

Quinoline derivatives as kinase inhibitors

N-(2-benzyloxy-1-phenethyl)-N-(2'-methoxyethyl)amino-methane compounds are useful as tachykinin antagonists